Vimarsana
Biggest News Aggregation in the World

Page 2 - Trial Design News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Design Today - Breaking & Trending Today

Pharmacists: Bispecifics and Operational Role - Vimarsana News

Pharmacists: Bispecifics and Operational Role

Robert Mancini, PharmD, reviews pharmacists’ pivotal role in operationalizing use of bispecifics in diffuse large B-cell lymphoma (DLBCL), overcoming challenges, and supporting direct patient care teams.

Strategies for Reducing Bispecific Therapy Toxicities - Vimarsana News

Strategies for Reducing Bispecific Therapy Toxicities

Experts discuss strategies to reduce treatment-related toxicities in bispecific antibody treatments, emphasizing clarity on dosing, hydration, and safety concerns.

Multidisciplinary Bispecific Care - Vimarsana News

Multidisciplinary Bispecific Care

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, and Amir Ali, PharmD, BCOP, FHOPA, delve into bispecific antibody treatments, focusing on strategies for patient safety and optimizing care in the management of cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome.

Bispecific Toxicity Management in DLBCL Care - Vimarsana News

Bispecific Toxicity Management in DLBCL Care

Robert Mancini, PharmD, discusses bispecific therapy advancements and strategies to manage adverse effects in diffuse large B-cell lymphoma (DLBCL) care, offering insights on toxicity phases, monitoring, and patient care.

Implementing Bispecific Treatments - Vimarsana News

Implementing Bispecific Treatments

Panelists explore the challenges, implementations, and decision-making processes surrounding bispecific treatments in DLBCL (diffuse large B cell lymphoma).